Shows
The HealthPodIts an MDMA kind of dayThis episode we revisit another psychedilic MDMA. Its crazy how there are people that abhorrently deny the benefit of these "recreational" drugs. I am giving some brief data on how MDMA can prove useful.'
MAPS clinical trial- http://bit.ly/2FNZP78
Current Perspective on MDMA-Assisted Psychotherapy for Posttraumatic Stress Disorder -http://bit.ly/2I4Q6eb
2019-04-0115 minThe HealthPodStop at your doctor's before your next RaveMove over anti-depressents there's a new MOA in town. This episode details a new intranasal ketamine produce by Janssen pharmaceuticals.
This is a brief look at the data we have so far. Enjoy!
SPRAVATO- http://bit.ly/2URxZfv
Pharmacology of Ketamine study- http://bit.ly/2HyzETT
2019-03-2014 minThe HealthPodMorning drugsThis episode delves into a drug that most of us need on a daily basis. CAFFEINE. This wonder molecule affects so many of our body's processes.
If your curious how it works and what makes it affect you so profoundly, give this episode a listen.
Enjoy!
Genetics of caffeine consumption and responses to caffeine- http://bit.ly/2XJDSwY
2019-03-0724 minThe HealthPodStatins under 30 part 2This episode revisits why statins and if they are as beneficial as currently believed. There are many nuances about statins and confusion. Hopefully this episode clears things up!
Saturated fat is not the major issue -http://bit.ly/2GxkgH9
Low-Density Lipoprotein Cholesterol Lowering for the Primary Prevention of Cardiovascular Disease Among Men With Primary Elevations of Low-Density Lipoprotein Cholesterol Levels of 190 mg/dL or Above - http://bit.ly/2T9e5P8
Interpretation of the evidence for the efficacy and safety of statin therapy - http://bit.ly/2T9Sbvv
Long-term m...
2019-02-1936 minThe HealthPodPresident Trump's State of the Union addressThis episode is going to go over what I found related the most to in the state of the union address to healthcare. There were many outlandish claims but this address could have been way worse than it turned out.
https://wb.md/2GtrTgR
2019-02-0706 minThe HealthPodFlu upswing and a new Advair genericThis episode is a brief synopsis on trends in the Flu season so far and a new FDA generic approval of a long standing respiratory inhaler.
Influenza upswing- https://wb.md/2UJFnJm
Advair generic- https://wb.md/2TyoD7r
2019-02-0607 minThe HealthPodRecalls on Recalls!FDA statement on ARBs recalls- http://bit.ly/2DVNxZA
Ibuprofen Recall by Tris Pharm Inc.- http://bit.ly/2RKKzLa
The various lots recalled include:
Lot 4718 — sold in a .5 oz. bottle with an expiration date of Dec. 2019 — and lot 00717006A — sold in a 1 oz. bottle with an expiration date of Feb. 2019 — were manufactured under the "CVS Health" label, according to the release. Lot 00717005A — sold in a 1 oz. bottle with an expiration date of Feb. 2019 — was manufactured under the "Equate" label for Walmart.
2019-02-0507 minThe HealthPodWhat's new with the opioid epidemic?This episode is a brief update on the opioid epidemic.
A Perspective Regarding the Current State of the Opioid Epidemic. | Psychiatry | JAMA Network Open | JAMA Network- http://bit.ly/2WEZaLw
FDA announcemet- http://bit.ly/2DQh8TW
2019-02-0411 minThe HealthPodN.Y.C universal health care and Mega infectionThis episode is the introduction into my new format of shorter and more digestible episodes.
N.Y.C healthcare- https://wb.md/2UzRA
Wyoming patient infected- https://wb.md/2GhTaTw
2019-02-0107 minThe HealthPodClot permeability and Xarelto, Flu data, ARB recalls, Celgene aquisition1. Clot permeability and Thrombolytic risk: https://wb.md/2CVGv6t What is clot permeability: http://bit.ly/2CVFD1H 2. Andexxa Commercial Production Approval: https://wb.md/2CThfOe 3. Flu data: https://wb.md/2Vx0Q9s CDC Reports: http://bit.ly/2CVaTO8 4. Sartan Saga: https://wb.md/2FfgukM Aurobindo: http://bit.ly/2GXqjpu Torrent: http://bit.ly/2saUsqY 5. Mediterranean vs. Dash Diet in U.S Rankings: https://wb.md/2Ca1D7d 6. Celgene acquisition: https://read.bi/2AyHt6S
2019-01-0719 minThe HealthPodFlu updates and high risksWhat better way to start the year then with staying on top of healthcare. This episode covers the new flu guidelines, a novel mechanism in schizophrenia, and Newly found risk of basal insulin and sulfonylureas. IDSA influenza guidelines- http://bit.ly/2QYLM5Q Novel schizophrenia molecule SEP-363856 - http://bit.ly/2QaiFr3 What is a PANSS test- http://bit.ly/2GOhCOa New emergent risks with Basal insulin and Sulfonylureas- http://bit.ly/2QXF1kG New flu medication Xofluza (baloxivir marboxil) - http://bit.ly/2EWt9s5
2018-12-3123 minThe HealthPodValsartan recall update, VTE risk reduction, and Novel therapiesThis week I review what's going on with the Valsartan recall, VTE risk reduction in prophylaxis, Increased death in children with antipsychotics, new cannabis therapy, and new use for modafinil. 1. Valsartan recall https://wb.md/2EBred0 FDA warning letter: http://bit.ly/2STOdTF 2. Apixiban Reduction of VTE risk in Cancer Patients: https://wb.md/2rKavvI AVERT Study: http://bit.ly/2CkGGYS 3. Antipyschotics linked to increased mortality in young patients https://wb.md/2CkRg1S Full study: http://bit.ly/2BBV3Xd 4. Cannabis use disorder https://wb.md/2LoZ9q7 Full study for purchase: http://bit.ly/2S8lyub 5. Modafinil for...
2018-12-1830 minThe HealthPodMore Valsartan recalls! Drug approvals, and Cholesterol medicationsThis episode reviews what has happened in the previous week in healthcare. For more information on the topics discussed please see the links provided.
Valsartan recall: https://www.medscape.com/viewarticle/906158
FDA list of recent Mylan lots: https://www.fda.gov/Safety/Recalls/ucm627647.htm?utm_campaign=FDA%20updates%20on%20angiotensin%20II%20receptor%20blocker%20(ARB)%20recalls:%20Mylan%20expands&utm_medium=email&utm_source=Eloqua
This Table will go over "NDMA" levels not NDEA as mentioned. NDEA results will be released at a later date: https://www.fda.gov/Drugs/DrugSafety/ucm622717.htm
Medications other than statins: https://www.medscape.com...
2018-12-1220 minThe HealthPodStatins under 30 part 1Ever wonder why take a statin? Especially if your young and beautiful other health problems. Take a listen to this podcast and learn why.
2018-12-0809 minThe HealthPodValsartan recalls, new guidelines, and cancer drugsThis episode goes into some more valsartan recalls, AML drugs and AHA HTN guidelines controversy, and lipid guidelines
2018-12-0323 minThe HealthPodWeek 11/28/181. Valsartan recall 2. Travelers diarrhea 3. AML 4. Supplement contamination 5. Chicago shooting
2018-11-2617 min